Jeffrey Capello joins Flex Pharma's board
This article was originally published in Scrip
Executive Summary
Flex Pharma, a biotechnology company developing innovative treatments for exercise-associated muscle cramps, nocturnal leg cramps, and spasms associated with severe neuromuscular conditions, has named Jeffrey D Capello to its board of directors. Mr Capello is currently chief financial officer of Ortho-Clinical Diagnostics. He will also become chair of Flex's audit committee.